- Home
- RVP vs DYAI Comparison
RVP vs DYAI Comparison
Compare RVP & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- DYAI
- Stock Information
- Founded
- RVP 1994
- DYAI 1979
- Country
- RVP United States
- DYAI United States
- Employees
- RVP N/A
- DYAI N/A
- Industry
- RVP Medical/Dental Instruments
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVP Health Care
- DYAI Health Care
- Exchange
- RVP Nasdaq
- DYAI Nasdaq
- Market Cap
- RVP 29.2M
- DYAI 30.2M
- IPO Year
- RVP 2001
- DYAI 2004
- Fundamental
- Price
- RVP $0.82
- DYAI $0.97
- Analyst Decision
- RVP
- DYAI Strong Buy
- Analyst Count
- RVP 0
- DYAI 2
- Target Price
- RVP N/A
- DYAI $4.50
- AVG Volume (30 Days)
- RVP 229.4K
- DYAI 70.7K
- Earning Date
- RVP 11-14-2025
- DYAI 11-12-2025
- Dividend Yield
- RVP N/A
- DYAI N/A
- EPS Growth
- RVP N/A
- DYAI N/A
- EPS
- RVP N/A
- DYAI N/A
- Revenue
- RVP $38,161,712.00
- DYAI $4,135,078.00
- Revenue This Year
- RVP N/A
- DYAI $18.18
- Revenue Next Year
- RVP N/A
- DYAI $87.65
- P/E Ratio
- RVP N/A
- DYAI N/A
- Revenue Growth
- RVP N/A
- DYAI 129.20
- 52 Week Low
- RVP $0.56
- DYAI $0.71
- 52 Week High
- RVP $1.14
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- RVP 40.91
- DYAI 37.18
- Support Level
- RVP $0.83
- DYAI $1.07
- Resistance Level
- RVP $0.89
- DYAI $1.21
- Average True Range (ATR)
- RVP 0.06
- DYAI 0.11
- MACD
- RVP -0.02
- DYAI -0.02
- Stochastic Oscillator
- RVP 8.99
- DYAI 9.22
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.